Cargando…
Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Radiological Society of North America
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096715/ https://www.ncbi.nlm.nih.gov/pubmed/35471114 http://dx.doi.org/10.1148/radiol.220962 |
| _version_ | 1784706037602844672 |
|---|---|
| author | Moy, Linda Kim, Eric |
| author_facet | Moy, Linda Kim, Eric |
| author_sort | Moy, Linda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9096715 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Radiological Society of North America |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90967152022-05-13 Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary Moy, Linda Kim, Eric Radiology Reviews and Commentary Radiological Society of North America 2022-04-26 /pmc/articles/PMC9096715/ /pubmed/35471114 http://dx.doi.org/10.1148/radiol.220962 Text en © 2022 by the Radiological Society of North America, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Reviews and Commentary Moy, Linda Kim, Eric Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary |
| title | Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary |
| title_full | Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary |
| title_fullStr | Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary |
| title_full_unstemmed | Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary |
| title_short | Follow-up of COVID-19 Vaccine–related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary |
| title_sort | follow-up of covid-19 vaccine–related axillary lymphadenopathy before 12 weeks is unnecessary |
| topic | Reviews and Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096715/ https://www.ncbi.nlm.nih.gov/pubmed/35471114 http://dx.doi.org/10.1148/radiol.220962 |
| work_keys_str_mv | AT moylinda followupofcovid19vaccinerelatedaxillarylymphadenopathybefore12weeksisunnecessary AT kimeric followupofcovid19vaccinerelatedaxillarylymphadenopathybefore12weeksisunnecessary |